Our results showed an increase in CD-44 positive staining in Nuak2-OE tumors compared to control tumor-bearing mice, while Nuak2-CR tumors had significantly fewer Ki67, PCNA, and CD-44 positive cells (Fig. 5E–I). This evidence concerns the gene CD44 and neoplasm.